Wishing you all the joys of the season! 
South & Central America Bioprocess Technology Market Forecast to 2028
South & Central America Bioprocess Technology Market Forecast to 2028 – Regional Analysis By Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, and Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Introducing Advanced Bioprocess Technologies Drives South & Central America Bioprocess Technology Market
Advanced bioprocess technologies bridge R&D with production. Several players are introducing a wide range of new bioprocessing technologies in the market. On December 4, 2020, IDBS (a provider of software informatics solutions for the biotech and pharmaceutical industries) announced the launch of Polar. Polar creates a new product category called BioPharma Lifecycle Management (BPLM) to streamline drug development and production in biopharma research. Polar is designed and deployed to rapidly solve challenges associated with workflow, process quality, collaboration, and data analysis that have plagued the existing software solutions, including laboratory information management system (LIMS) and electronic laboratory notebook (ELN). As a result, there will be less human errors and an improvement in overall accuracy. It will reduce manual data processing and transcription, leading to fewer human errors and enhanced overall accuracy. It also has extensive search features that make it easier for users to locate what they are searching for, preventing the need for pointless duplication of effort.
METTLER TOLEDO’s Dynochem Biologics is a purpose-built simulation software that supports upstream and downstream unit activities in bioprocessing at any scale. Bioprocess engineers and scientists use the software to choose appropriate process operating parameters and establish scales equivalency. Utilities enable quick evaluation of equipment performance with minimal data, whereas more potent models leverage the existing data streams for process characterization. Initial projects can be completed quickly with the help of responsive application expertise, rich training resources, and a model library that is already built. Peptides, mAbs, vaccinations, and viral vectors are a few examples of the many applications.
Merck’s new BioContinuum Platform advances biotherapeutic drug manufacturing through improved efficiency, simplified plant operations, and greater quality and consistency. In addition, Merck’s Pellicon Single-Pass Tangential Flow Filtration aid in intensifying operations associated with the purification of therapeutic proteins. Thus, the introduction of various new-age bioprocess technologies is likely to provide lucrative opportunities for the market growth during the forecast period.
South & Central America Bioprocess Technology Market Overview
The bioprocess activity produces purified protein derivative (PPD) using Brazilian strains intended for diagnostic use, per the National Institute of Health (NIH) report. In Brazil, the healthcare system imports and distributes the PPD across various areas. The indigenous production of PPD was undertaken to initiate studies toward developing an indigenous technology for PPD production using the strains of Mycobacterium tuberculosis isolated from patients suffering from TB across Brazil. Therefore, PPD reveals similar indications when tested individually, and better results were obtained. Such advancements in producing strains for targeted therapy through strains are responsible for significant growth for the South & Central America bioprocess technology market during the forecast period.
South & Central America Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Bioprocess Technology Market Segmentation
The South & Central America bioprocess technology market is segmented into type, modality, end user, and country.
Based on type, the South & Central America bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. In 2023, the consumables & accessories segment registered the largest share in the South & Central America bioprocess technology market.
Based on modality, the South & Central America bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the South & Central America bioprocess technology market.
Based on end-use, the South & Central America bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered the largest share in the South & Central America bioprocess technology market.
Based on country, the South & Central America bioprocess technology market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2023, the Rest of South & Central America segment registered a largest share in the South & Central America bioprocess technology market.
Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; and Thermo Fisher Scientific Inc are some of the key companies operating in the South & Central America bioprocess technology market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team’ research, the South & Central America bioprocess technology market was valued at US$ 1,531.47 million in 2023 and is expected to reach US$ 3,361.13 million by 2028, registering a CAGR of 17.0% from 2023 to 2028. Growing R&D spendings to introduce new drug compounds and introducing advanced bioprocess technologies are the critical factors attributed to the South & Central America bioprocess technology market expansion.
Pharmaceutical companies are spending huge sum in R&D to introduce new molecules with enhanced medical and commercial potency for various therapeutic applications. Novartis, Roche, Johnson & Johnson, Merck & Co, GlaxoSmithKline, and Pfizer are among the world’s Top 10 companies with high R&D investments. The patent expiry of blockbuster molecules, a limited number of potential products in the pipeline, and the increasing demand for biologics have driven companies to adopt novel technologies, such as single-use bioprocessing technologies, in order to facilitate a quick cost-effective turnaround process for products. Single-use component and system manufacturers typically produce and assemble products in clean rooms to ensure they do not introduce harmful particulates and endotoxins into a bioprocess. Thus, high investments in R&D are made to introduce new drug compounds and aid in the development of bioprocessing technologies; these technologies support emerging biomanufacturing capabilities and related interoperability of raw materials, bioreactors, and unit operations.
On the contrary, stringent regulatory policies hurdles the growth of South & Central America bioprocess technology market.
Based on type, the South & Central America bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. The consumables & accessories segment held 44.7% share of South & Central America bioprocess technology market in 2023, amassing US$ 684.22 million. It is projected to garner US$ 1,494.98 million by 2028 to expand at 16.9% CAGR during 2023-2028.
Based on modality, the South & Central America bioprocess technology market is bifurcated into single use and multiple use. The single use segment held 74.9% share of South & Central America bioprocess technology market in 2023, amassing US$ 1,147.79 million. It is projected to garner US$ 2,470.63 million by 2028 to expand at 16.6% CAGR during 2023-2028.
Based on end-use, the South & Central America bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. The biopharmaceutical companies segment held 52.2% share of South & Central America Bioprocess technology market in 2023, amassing US$ 799.19 million. It is projected to garner US$ 1,738.94 million by 2028 to expand at 16.8% CAGR during 2023-2028.
Based on country, the South & Central America bioprocess technology market is segmented into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that the Rest of South & Central America captured 37.9% share of South & Central America bioprocess technology market in 2023. It was assessed at US$ 580.58 million in 2023 and is likely to hit US$ 1,254.04 million by 2028, exhibiting a CAGR of 16.7% during the forecast period.
Key players profiled in the South & Central America bioprocess technology market report are Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; and Thermo Fisher Scientific Inc, among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America bioprocess technology market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the bioprocess technology market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Bioprocess Technology Market – by Type
1.3.2 South & Central America Bioprocess Technology Market – by Modality
1.3.3 South & Central America Bioprocess Technology Market – by End User
1.3.4 South & Central America Bioprocess Technology Market – by Country
2. South & Central America Bioprocess Technology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Bioprocess Technology Market – Market Landscape
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. South & Central America Bioprocess Technology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies
5.3 Market Opportunities
5.3.1 Introducing Advanced Bioprocess Technologies
5.4 Future Trends
5.4.1 Emergence of Automated Real-Time Flow Cytometry (ART-FCM)
5.5 Impact Analysis
6. Bioprocess Technology Market – South & Central America Analysis
6.1 South & Central America Bioprocess Technology Market Revenue Forecast and Analysis
7. South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 South & Central America Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
7.3 Cell Culture Media Bioprocess
7.3.1 Overview
7.3.2 Cell Culture Media Bioprocess: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Chromatography Bioprocess
7.4.1 Overview
7.4.2 Chromatography Bioprocess: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Consumables & Accessories
7.5.1 Overview
7.5.2 Consumables & Accessories: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Bioprocess Technology Market Analysis and Forecasts to 2028 – by Modality
8.1 Overview
8.2 South & Central America Bioprocess Technology Market, by Modality 2022 & 2028 (%)
8.3 Single Use
8.3.1 Overview
8.3.2 Single Use: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Multiple Use
8.4.1 Overview
8.4.2 Multiple Use: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 South & Central America Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
9.3 Academic & Medical Institutions
9.3.1 Overview
9.3.2 Academic & Medical Institutions: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Biopharmaceutical Companies
9.4.1 Overview
9.4.2 Biopharmaceutical Companies: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Laboratories: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 – Country Analysis
10.1 Overview
10.1.1 South & Central America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
10.1.1.1 Brazil: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.1.4 Brazil: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.1.5 Brazil: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.1.2 Argentina: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.2.4 Argentina: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.2.5 Argentina: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.1.3 Rest of South & Central America: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South & Central America: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of South & Central America: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.3.4 Rest of South & Central America: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.3.5 Rest of South & Central America: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
11. South & Central America Bioprocess Technology Market – Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Merck KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sartorius AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Thermo Fisher Scientific Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Lonza Group AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Eppendorf SE
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Repligen Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Danaher Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Research Team
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
Table 2. Brazil Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Argentina Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 7. Argentina Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8. Rest of South & Central America Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Rest of South & Central America Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 10. Rest of South & Central America Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Recent Organic Growth Strategies in Bioprocess Technology Market
Table 12. Recent Inorganic Growth Strategies in the South & Central America bioprocess technology market
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. South & Central America Bioprocess Technology Market Segmentation
Figure 2. South & Central America Bioprocess Technology Market, by Country
Figure 3. South & Central America Bioprocess Technology Market Overview
Figure 4. Others Segment Held Largest Share of Type Segment in South & Central America Bioprocess Technology Market
Figure 5. Argentina Expected to Show Remarkable Growth During Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. South & Central America Bioprocess Technology Market Impact and Analysis
Figure 9. South & Central America Bioprocess Technology Market – Revenue Forecast and Analysis – 2020-2028
Figure 10. South & Central America Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
Figure 11. Cell Culture Media Bioprocess: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Chromatographic Bioprocess: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Consumables & Accessories: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. South & Central America Bioprocess Technology Market, by Modality 2022 & 2028 (%)
Figure 16. Single Use: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Use: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. South & Central America Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
Figure 19. Academic & Medical Institutions: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Biopharmaceutical Companies: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Research Laboratories: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. South & Central America: Bioprocess Technology Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. South & Central America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
Figure 25. Brazil: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Argentina: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Rest of South & Central America: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
The List of Companies – South & Central America Bioprocess Technology Market
o Danaher Corp
o Eppendorf SE
o Lonza Group AG
o Merck KGaA
o Repligen Corp
o Sartorius AG
o Thermo Fisher Scientific Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.